Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Emma Marie de Boo

19 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: https://openalex.org/A5116553231

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Safety 9 Depression 7 Review Article 7 Pharmacology 6 Receptor Pharmacology 6 Addiction 5 Neuroplasticity 4 Anxiety 4 Clinical Trial 4 Toxicity 4 Drug Interactions 3 Systematic Review 3

Journals

Psychoactives 2 European journal of drug metabolism and pharmacokinetics 1 Frontiers in Psychiatry 1 Neuropsychopharmacology 1 Translational Psychiatry 1 BJPsych Open 1 Current Psychiatry Reports 1 Journal of Psychopharmacology 1

Publication history

Development of a Physiologically Based Pharmacokinetic/Pharmacodynamic Model of Psilocybin/Psilocin from Psilocybe cubensis (Magic Mushroom) in Treatment-Resistant Depression.European journal of drug metabolism and pharmacokinetics · 2026-08-28 Psilocybin-containing mushroom-assisted psychotherapy is associated with sustained psychological and somatic improvements: two case studies from JamaicaFrontiers in Psychiatry · 2026-07-29 Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophreniaNeuropsychopharmacology · 2026-07-18 Prenatal stress, excitatory-inhibitory imbalance, and ADHD risk: a hypothesis-driven perspective on psilocybin-induced neuroplasticityTranslational Psychiatry · 2026-06-05 From Altered States to Altered Trajectories and From Molecules to Meaning: A Network Meta Analysis Mapping Comparative Efficacy of Psychedelic Assisted Therapies in Modern PsychiatryBJPsych Open · 2026-06-01 Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of CareCurrent Psychiatry Reports · 2026-05-14 A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorderJournal of Psychopharmacology · 2026-05-01 Distinguishing 4- vs 5-Hydroxy- N, N -Dimethyltryptamine (Psilocin vs Bufotenine) Using Hydrogen-Deuterium Back-ExchangeJournal of the American Society for Mass Spectrometry · 2026-02-04 Psychedelic research and sexuality: opportunities and pitfallsThe Journal of Sexual Medicine · 2026-01-28 Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild StressJournal of Psychoactive Drugs · 2026-01-02 Psychedelic DrugsIntechOpen · 2026-01-01 A Systematic Review of the efficacy, safety, and Tolerability of Psychedelics in the Treatment of post-traumatic Stress DisorderCurrent Treatment Options in Psychiatry · 2025-12-25 Neuroplasticity and Neuro-Generation: The Promise of Psychedelics in Dementia CarePsychoactives · 2025-09-02 Regulatory Challenges of Integrating Psychedelics into Mental Health SectorPsychoactives · 2025-04-22 Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humansScientific Reports · 2025-04-21 58. Acute Behavioral Effects of Psilocybin and Its Pharmacokinetics in Nonhuman PrimatesBiological Psychiatry · 2025-04-09 Pharmacokinetics of Psilocybin, a Tryptamine Alkaloid in Magic Mushroom (): A Systematic Review.Journal of psychoactive drugs · 2025-01-01 Nothing Ventured, Nothing Gained: Regulations Cripple Potentially Life-Saving Research of Illicit Substances.ACS chemical neuroscience · 2020-05-20 Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive DisorderYearbook of Psychiatry and Applied Mental Health · 2008-01-01

Author directory